Schedule 13G ownership disclosure

CARA THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 140755208

Event date: 2025-04-15

Filing-level shares
837,636
Percent of class
8.95%
  • Sporos Bioventures LLC

    Shares: 837,636 · Class: 8.95%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-105905
Form type
SCHEDULE 13G
Filer
Sporos Bioventures LLC
CIK
CIK 2072022
Filed
Aug 08, 2025
Reporting period
Apr 15, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub